Preparation of new monoanionic "scorpionate" ligands: synthesis and structural characterization of titanium(IV) complexes bearing this class of ligand

Structure and spectroscopic properties of etherates of the beryllium halides

The synthesis of beryllium halide etherates and the solution behavior in benzene, dichloromethane, and chloroform was studied by NMR, IR, and Raman spectroscopy. Mononuclear units of [BeX 2(L)2] (X = Cl, Br, I; L = Et2O, thf) were identified as the favorably formed species in solution. Treatment of the mononuclear diethyl ether beryllium halide adduct with one equivalent beryllium halide formed the dinuclear compounds [BeX 2(OEt2)]2 (X = Cl, Br, I). The solid-state structures of [BeCl2(thf)2] and [BeBr2(thf)2] have been determined by single crystal X-ray diffraction analysis. [BeI2(thf)2] decomposed in all solvents. In CD2Cl2 the salt [Be(thf)4]I2 was formed, whereas in C6D6 and CDCl3, BeI2 precipitated and [BeI(thf)3]+, [Be(thf)4]2+ together with the thf ring-opening product [Be(μ 2-O(CH2)4I)I(thf)]2 were observed in solution.

Phosphine-functionalised tris(pyrazolyl)methane ligands and their mono- and heterobimetallic complexes

The synthesis, characterisation and reactivity of new phosphine-functionalised tris(pyrazolyl)methane ligands (TpmPR₂, 2a-c, with R = Ph, nBu, iPr) are presented. The reaction of 2a-c with [Rh(CO)₂Cl]₂ furnished N,P-heterochelate carbonyl complexes (3a-c), which were used to quantify the donor abilities of the ligands via IR spectroscopy. The coordination flexibility was demonstrated by treating representative members of this new ligand class with [CpRu(acn)₃][PF₆] (acn = acetonitrile), [(tht)AuCl] (tht = tetrahydrothiophene) and [Pd(allyl)Cl]₂ providing either a N,N,P-heteroscorpionate complex (4) or the P-coordinated complexes (5,6) without any involvement of the pyrazolyl entities. With 2a and [Pd(cod)Cl₂], another P,N-heterochelate complex (7) was obtained, which served as a precursor for a heterobimetallic complex containing palladium and copper (8). Detailed NMR spectroscopic and X-ray crystallographic investigations have been performed on all new complexes.

Magnesium, calcium and zinc [N2N'] heteroscorpionate complexes

A new family of sterically demanding N2N' heteroscorpionate pro-ligands (HC(tBu2pz)2SiMe2N(H)R (R = iPr, tBu, Ph, Xyl)) has been prepared via a straightforward modular synthetic route. An extensive study into the synthesis and characterisation of lithium, magnesium, calcium and zinc complexes supported by both 3,5-tBu and 3,5-Me substituted N2N' ligand families has been conducted. Attempted deprotonation of the pro-ligands with nBuLi afforded the corresponding lithium salts Li{HC(tBu2pz)2SiMe2NR} (R = iPr (1), tBu (2), Ph (3) and Xyl (4)) but air- and thermal-sensitivity limited the yields of these potentially useful precursors; only the sterically encumbered ligand system allowed clean reactivity. Magnesium methyl complexes Mg{HC(tBu2pz)2SiMe2NR}Me (R = iPr (5) and R = Ph (6)) were prepared using an excess of the Grignard reagent MeMgCl. Magnesium butyl complexes were synthesised in good yields using the dialkyl precursor MgnBu2 to afford Mg{HC(R'2pz)2SiMe2NR}nBu (R' = Me; R = iPr (7), tBu (8), Ad (9), Ph (10). R' = tBu; R = iPr (11), Ph (12)). Protonolylsis reactions were used to synthesise magnesium and calcium amide complexes Mg{HC(R'2pz)2SiMe2NR}{N(SiHMe2)2} (R' = Me; R = iPr (13), tBu (14), Ph (15). R' = tBu; R = Ph (16)) or Mg{HC(R'2pz)2SiMe2NR}{N(SiMe3)2} (R' = Me; R = iPr (17), tBu (18), Ph (19). R' = tBu; R = Ph (20)), and Ca{HC(R'2pz)2SiMe2NR}{N(SiMe2)2} (L) (R' = Me; L = thf; R = iPr (21), tBu (22), Ph (23). R' = tBu; L = none; R = Ph (24). Zinc methyl complexes Zn{HC(R'2pz)2SiMe2NR}Me (R' = Me; R = iPr (25), tBu (26), Ph (27). R' = tBu; R = Ph (28)) were prepared by reaction of the N2N' heteroscorpionate pro-ligands with ZnMe2. In preliminary studies, magnesium amide complexes 16 and 20 were evaluated as initiators for the ring-opening polymerisation (ROP) of ε-caprolactone (ε-CL) and rac-lactide (rac-LA). Although the overall polymerisation control was poor, 16 and 20 were found to be active initiators.

Synthesis of new heteroscorpionate iridium(i) and iridium(iii) complexes

The reactivity of different heteroscorpionate ligands based on bis(pyrazol-1-yl)methane, with different iridium-(i) and -(iii) precursors is reported.

Synthesis, structure, and catecholase activity of bispyrazolylacetate copper(ii) complexes

Heteroleptic copper(ii) complexes containing bis(3,5-di-t-butylpyrazol-1-yl)acetate and nitrogen heterocyclic co-ligands identified the influence of co-ligands on the conformation and catecholase-like catalytic activity.

Heteroscorpionate complexes based on bis(3,5-di-tert-butylpyrazol-1-yl)dithioacetate

The heteroscorpionate ligand bis(3,5-di-tert-butylpyrazol-1-yl)dithioacetate (bdtbpzdta) has been synthesized by reacting bis(3,5-di-tert-butylpyrazol-1-yl)methane with n-BuLi and CS2. The ligand was isolated as [bis(3,5-di-tert-butylpyrazol-1-yl)dithioacetato](tetrahydrofuran)lithium(I) tetrahydrofuran monosolvate, [Li(C24H39N4S2)(C4H8O)]·C4H8O or [Li(bdtbpzdta)(THF)]·THF, in which the lithium cation is bound by the κ(3)N,N',S-coordinated heteroscorpionate ligand. A similar coordination mode is observed for a zinc chloride complex bearing the bdtbpzdta ligand, namely [bis(3,5-di-tert-butylpyrazol-1-yl)dithioacetato]chloridozinc(II), [Zn(C24H39N4S2)Cl] or [Zn(bdtbpzdta)Cl], which exhibits κ(3)N,N',S-coordination and resembles the active site of zinc-containing peptide deformylases (PDFs).

Heteroscorpionate-based Co2+, Zn2+, and Cu2+ complexes: coordination behavior, aerobic oxidation, and hydrogen sulfide detection

The coordination behavior and reactivity of the phenol-substituted bis(pyrazolyl)methane ligands, (3,5-(t)Bu(2)-2-phenol)bis(3,5-Me(2)-pyrazol-1-yl)methane (L1-H) and 2-phenol-bis(3,5-Me(2)-pyrazol-1-yl)methane (L2-H) have been investigated in the metal complexes (L1-H)CoCl(2) (1), (L1-H)ZnCl(2) (2), (L3)CuCl(2) (3), (L2)(2)Co(2)Cl(2) (4) (L2-H)ZnCl(2) (5), and (L2-H)CuCl(2)·H(2)O (6). The mononuclear tetrahedral cobalt complex 1 was isolated and fully characterized by X-ray single crystal diffraction and (1)H NMR spectroscopy and relaxometry. The neutral L1-H is κ(2)-coordinated to the metal center whereas the not coordinated hydroxy-phenyl group is involved in extended intermolecular hydrogen bonds. Aerobic oxidation of L1-H was observed in the reaction of this ligand with CuCl(2) to yield the para-quinone derivative L3 (L3 = 2-(t)Bu-6-(bis(3,5-Me(2)-pyrazol-1-yl)methyl)cyclohexa-2,5-diene-1,4-dione). Upon oxidation L3 resulted κ(2)-coordinated to the tetrahedral Cu(II) metal center, affording 3. The reaction of L2-H with CoCl(2)·6H(2)O produced the elimination of 1 equiv of hydrochloric acid and the formation of the binuclear complex 4 in which one cobalt is in an octahedral environment featuring two κ(3)-coordinated deprotonated ligands whereas the second cobalt center is detected in tetrahedral coordination geometry, bound to the octahedral cobalt via two phenoxo bridging moieties. Interestingly L2-H, (3-(t)Bu-2-phenol)bis(3,5-Me(2)-pyrazol-1-yl)methane (L4-H), or (5-(t)Bu-2-phenol)bis(3,5-Me(2)-pyrazol-1-yl)methane (L5-H) were not oxidized in the reaction with CuCl(2). The reaction of the ligand L2-H with ZnCl(2) and CuCl(2)·2H(2)O yielded the κ(2)-coordinated tetrahedral complex 5 and the square planar complex 6, respectively. The application of the cobalt complex 1 as molecular dosimeter for H(2)S was explored and compared to that of the zinc analogue 2. Density functional theory (DFT) calculations and NMR experiments to assess the possible mechanisms of H(2)S detection by both 1 and 2 are also described.

Versatile scorpionates and new developments in the denticity changes of NNCp hybrid scorpionate/cyclopentadienyl ligands in Sc and Y compounds: from kappa1-Neta5-Cp to kappa2-NNeta5-Cp

Reaction of hybrid scorpionate/cyclopentadienyl ligands in the form of the lithium derivatives [Li(bpzcp)(THF)] [bpzcp=2,2-bis(3,5-dimethylpyrazol-1-yl)-1,1-diphenylethylcyclopentadienyl], [Li(bpztcp)(THF)] [bpztcp=2,2-bis(3,5-dimethylpyrazol-1-yl)-1-tert-butylethylcyclopentadienyl], and the in situ-generated "Li(bpzpcp)" [bpzpcp=2,2-bis(3,5-dimethylpyrazol-1-yl)-1-phenylethylcyclopentadienyl] with MCl3(THF)3 afforded the group 3 halide compounds [MCl2(bpzcp)(THF)] (M=Sc, 1; Y, 2), [MCl2(bpztcp)(THF)] (M=Sc, 3; Y, 4), and [MCl2(bpzpcp)(THF)] (M=Sc, 5; Y, 6). The H2O adduct of 4, [YCl2(bpztcp)(H2O)] (7), was formed when a solution of 4 was allowed to stand at room temperature in the presence of moisture. Complexes 1-7 adopt a pseudo-octahedral structure with heteroscorpionate ligands kappa2-NNeta5-Cp coordinated to the metal through the cyclopentadienyl group and two imino nitrogens of pyrazole rings. The alkyl heteroscorpionate scandium and yttrium complexes recently reported by our group, [M(CH2SiMe3)2(bpzcp)], react with 2,6-dimethylphenol and 3,5-dimethylphenol to give the bis(aryloxide) derivatives [M(OAr)2(bpzcp)] (M=Sc, OAr=2,6-dimethylphenoxide, 8; M=Y, OAr=2,6-dimethylphenoxide, 9; M=Y, OAr=3,5-dimethylphenoxide, 10). Complex 9 underwent an interesting hydrolysis process to give the tetranuclear complex [{Y(bpzcp)}(micro-OH)2(micro3-OH){Y(OAr)2}]2 (11). Variable-temperature 1H NMR experiments on 9 and 10 revealed a rapid fluxional exchange between coordinated and noncoordinated pyrazolyl rings, producing interconversion between the two enantiomers in which the scorpionate ligand can be coordinated in a kappa1-Neta5-Cp form. The structures of the complexes were determined by spectroscopic methods and the X-ray crystal structures of 2, 7, and 11 were also established. Complexes 1 and 2 are active olefin polymerization catalysts after activation with methylaluminoxane. These compounds gave atactic polystyrenes with narrow molecular weight distribution (Mn/Mw 1.26-1.91) and with low molecular weights.

Lithium, Titanium, and Zirconium Complexes with Novel Amidinate Scorpionate Ligands

The reaction of bis(3,5-dimethylpyrazol-1-yl)methane (bdmpzm) with BunLi and carbodiimide derivatives, namely, N,N'-diisopropyl, dicyclohexyl, and 1-tert-butyl-3-ethyl carbodiimides, enables the preparation of new heteroscorpionate ligands in the form of the lithium derivatives [Li(NNN)(THF)] (NNN = pbpamd (1) (pbpamd = N,N'-diisopropylbis(3,5-dimethylpyrazol-1-yl)acetamidinate); cbpamd (2) (cbpamd = N,N'-dicyclohexylbis(3,5-dimethylpyrazol-1-yl)acetamidinate); and tbpamd (3) (tbpamd = N-ethyl-N'-tert-butylbis(3,5-dimethylpyrazol-1-yl)acetamidinate)), although a similar process with N,N'-dimethylcarbodiimide gave the dinuclear complex [Li(bpzii)(THF)]2 (4) (bpzii = N-(dimethylamino)-N'-[(dimethylamino)bis(3,5-dimethylpyrazol-1-yl)methylimino]imino). When this last reaction was carried out in an air atmosphere, the cluster complex [Li8(mu4-O)2(mu4-OH)2(mu4-pz)2(kappa2-bpziLi)2(bpzCN)2(THF)4] (5) (bpziLi = dimethylaminobis(3,5-dimethylpyrazol-1-yl)methyliminolithium, bpzCN = bis(3,5-dimethylpyrazol-1-yl)acetonitrile) was isolated and characterized by X-ray analysis. Finally, when the same process was carried out in the presence of water the amidine-scorpionate (bpzan) (6) (bpzan = N,N-dimethylbis(3,5-dimethylpyrazol-1-yl)acetamidine) was obtained. Compounds 1 and 3 reacted with [TiCl4(THF)2] or [ZrCl4] to give complexes of stoichiometry [MCl3((kappa3-NNN))] (M = Ti, Zr) (7-10). The structures of the different compounds were determined by spectroscopic methods and, in addition, the X-ray crystal structures of 1, 3, 4, 5, and 6 were also established.

Synthesis, Characterization, and in Vitro Antitumor Properties of Tris(hydroxymethyl)phosphine Copper(I) Complexes Containing the New Bis(1,2,4-triazol-1-yl)acetate Ligand

The new sodium bis(1,2,4-triazol-1-yl)acetate ligand, Na[HC(CO(2))(tz)(2)], has been prepared in methanol solution by using 1,2,4-triazole, dibromoacetic acid, and NaOH. Treatment of the [Cu(CH(3)CN)(4)][PF(6)] acceptor with Na[HC(CO(2))(tz)(2)] or Na[HC(CO(2))[(pz(Me2))(2)] in the presence of the tris(hydroxymethyl)phosphine coligand in methanol/acetonitrile solutions produced unprecedented mononuclear copper(I) complexes of the [L(n)]Cu[P(CH(2)OH)(3)](2) (L(1), 2; L(2), 3) [(CH(3)CN)(2)Cu(P(CH(2)OH)(3))(2)]PF(6), 4. These compounds have been characterized by elemental analyses, FTIR, ESI-MS, and multinuclear (1H and 31P) NMR spectral data. The new copper(I) complexes were tested for their cytotoxic properties against a panel of several human tumor cell lines. The results reported here indicate that all the complexes showed in vitro antitumor activity similar or better than that of cisplatin, the most used metal-based antitumor drug. In particular, [HC(CO(2))(pz(Me2))(2)]Cu[P(CH(2)OH)(3)](2), 3 showed IC(50) values markedly lower than the reference compound against all tumor cell lines. Chemosensitivity tests performed on cisplatin sensitive and resistant cell lines have demonstrated that all these Cu(I) complexes were able to overcome cisplatin resistance, supporting the hypothesis of a different mechanism of action compared to that exhibited by the reference drug. Flow cytometric analysis on 2008 human ovarian carcinoma cells revealed that complex 3, chosen as the best candidate, induced a marked enlargement of both cell size and granularity, and a significant increase in the fraction of G2/M cells that, differently from cisplatin, was not accompanied by the appearance of a relevant sub-G1 fraction. Besides, no evidence of caspase-3 activation was detected in cells treated with complex 3. We hypothesize that the cytotoxic activity of the new copper(I) complex may be correlated to its ability to trigger paraptosis, a nonapoptotic mechanism of cell death.